Photodynamic Therapy Market by product type, by devices, by application and by Region – Global Industry Analysis, Market Share, Trends, Size, and Forecasts to 2019 – 2027.

Photodynamic Therapy Market by product type, by devices, by application and by Region – Global Industry Analysis, Market Share, Trends, Size, and Forecasts to 2019 – 2027.

Market Scenario

Global Photodynamic Therapy Market was valued US$ 1125.XX Mn in 2018 and is expected to reach US$ 17XX.XX Mn by 2027, at CAGR of 5.XX% during forecast period of 2019 to 2027.   The global photodynamic therapy market is emerging with huge attraction towards its therapy as it provides effective treatment process and minimal side effects. There are drastic advancement in medical research due to which the market is expanding into different treatment processes and becoming popular worldwide. Photodynamic therapy is cost effective, nominally painful and offers numerous advantages for cancer patients as it helps them to sidestep the chemotherapy or surgery. The report study has analyzed revenue impact of covid-19 pandemic on the sales revenue of market leaders, market followers and disrupters in the report and same is reflected in our analysis. The photodynamic therapy involves the phototherapy treatment drugs and light therapy devices. Photodynamic therapy devices use the high-intensity bright light, which generate the dormant photosensitizer drugs when they are injected into the patient’s body. Among cancer patient popularity of light therapy is rising significantly which in turn drives the Photodynamic therapy market. Furthermore, photodynamic therapy is proved to be beneficial over chemotherapy as it can be repeated multiple times in one particular area. The Global Photodynamic Therapy Market dynamics are thoroughly studied and explained in the report, which helps reader to understand emerging market trends, drivers, restraints, opportunities, and challenges at global and regional level for the Global Photodynamic Therapy Market.  

Global Photodynamic Therapy Market is studied by Various Segments:

The analysts at Maximize Market Research have done an extensive research for the Global Photodynamic Therapy Market and provides the report with detail study of the market by various segments and by region:

• Global Photodynamic Therapy Market by Product Type

 Photosenitizer drugs  Hematoporphyrin Derivative (Hpd)  Aminolevulinic Acid (ALA)  Benzoporphyrin Derivatives  Texaphyrins  Chlorins  Dyes

• Global Photodynamic Therapy Market by Devices

 Disposable fiber optic light delivery devices  Diode lasers

• Global Photodynamic Therapy Market by Application

 Basal Cell Carcinoma  Actinic Keratosis  Other Photodynamic Therapy Market report is segmented on product type, by devices, by application and by regional & country level. Based upon product type, market is segmented by photodynamic drug which is further classified into Hematoporphyrin Derivative (HpD), Aminolevulinic Acid (ALA), benzoporphyrin derivatives, texaphyrins, chlorins and dyes. Segment Devices is divided into Disposable fiber optic light delivery devices and Diode lasers. Based upon application, photodynamic therapy market is classified into basal cell carcinoma, actinic keratosis and other. Global Photodynamic Therapy Market Region wise Market Analysis & Forecast: The report covers a geographic breakdown and a detailed analysis of each of the segments across region North America, Europe, Asia Pacific, and LAMEA. • North America  U.S.  Canada  Mexico • Europe  Germany  France  UK  Italy  Spain  Rest of Europe • Asia Pacific  Japan  China  India  Rest of Asia-Pacific • LAMEA  Latin America  Middle East  Africa The North American region is mounting in photodynamic therapy market due to rising number of skin cancers and increasing diagnostic facilities helping in detecting diseases at an early stage. The global photodynamic therapy market is evolving and expanding its reach in this region. The Europe market is experiencing growth due to increasing cases of cosmological disorder. The growing population and dermatological cases in many countries from region Asia Pacific is supplementing the photodynamic therapy market. Global Photodynamic Therapy Market: Competition Landscape The Global Photodynamic Therapy Market has the presence of a large number of players. Major players in the Global Photodynamic Therapy Market are concentrating on developing new technologies to facilitate the industry with lowest time and low expenditure consuming technologies. In the recent years there are many discoveries in the field of technologies with regards to Global Photodynamic Therapy Market, which in turn will help the industry to grow resulting in boost to the competition too. Detailed analysis of competition, new entrants, strategic alliances, mergers and acquisition in the Global Photodynamic Therapy Market is covered in the report. The report covers the market leaders and followers in the industry with the market dynamics by region. It will also help to understand the position of each player in the market by region, by segment with their expansion plans, R&D expenditure and organic & in-organic growth strategies. Long term association, strategic alliances, supply chain agreement and mergers & acquisition activities are covered in the report in detail from 2014 to 2019. Expected alliances and agreement in forecast period will give future course of action in the market to the readers. All major & important players are profiled, benchmarked in the report on different parameters that will help reader to gain insight about the market in minimum time.

Global Photodynamic Therapy Market Company Profiles –

The major players operating in the Global Photodynamic Therapy Market, analyzed in the report are: • Sun Pharmaceutical Industries Ltd. • Hologic, Inc. • Allergan Plc. • Galderma SA • Quest PharmaTech Inc. • Biofrontera AG • anofi • DUSA Pharmaceuticals • Bausch Health • Beiersdorf • Soligenix • Theralase Technologies • Quest Pharmatech • Galderma • Biofrontera • Lumenis • PhotoMedex • Biolitec • Ambicare Health Objective of the Report: The objective of the report is to present a comprehensive analysis of Global Photodynamic Therapy Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all aspects of the industry with a dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market are presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding Global Photodynamic Therapy Market dynamics, structure by analyzing the market segments and project the Global Photodynamic Therapy Market size. Clear representation of competitive analysis of key players by type, price, financial position, product portfolio, growth strategies, and regional presence in the Global Photodynamic Therapy Market make the report investor’s guide.

Table of Contents

Global Photodynamic Therapy Market 1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Photodynamic Therapy Market Size, by Market Value (US$ Mn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global Photodynamic Therapy Market Analysis and Forecast 6.1. Global Photodynamic Therapy Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Photodynamic Therapy Market Analysis and Forecast, by Product Type 7.1. Introduction and Definition 7.2. Key Findings 7.3. Global Photodynamic Therapy Market Value Share Analysis, by Product Type 7.4. Global Photodynamic Therapy Market Size (US$ Mn) Forecast, by Product Type 7.5. Global Photodynamic Therapy Market Analysis, by Product Type 7.6. Global Photodynamic Therapy Market Attractiveness Analysis, by Product Type 8. Global Photodynamic Therapy Market Analysis and Forecast, by Devices 8.1. Introduction and Definition 8.2. Key Findings 8.3. Global Photodynamic Therapy Market Value Share Analysis, by Devices 8.4. Global Photodynamic Therapy Market Size (US$ Mn) Forecast, by Devices 8.5. Global Photodynamic Therapy Market Analysis, by Devices 8.6. Global Photodynamic Therapy Market Attractiveness Analysis, by Devices 9. Global Photodynamic Therapy Market Analysis and Forecast, by Application 9.1. Introduction and Definition 9.2. Key Findings 9.3. Global Photodynamic Therapy Market Value Share Analysis, by Application 9.4. Global Photodynamic Therapy Market Size (US$ Mn) Forecast, by Application 9.5. Global Photodynamic Therapy Market Analysis, by Application 9.6. Global Photodynamic Therapy Market Attractiveness Analysis, by Application 10. Global Photodynamic Therapy Market Analysis, by Region 10.1. Global Photodynamic Therapy Market Value Share Analysis, by Region 10.2. Global Photodynamic Therapy Market Size (US$ Mn) Forecast, by Region 10.3. Global Photodynamic Therapy Market Attractiveness Analysis, by Region 11. North America Photodynamic Therapy Market Analysis 11.1. Key Findings 11.2. North America Photodynamic Therapy Market Overview 11.3. North America Photodynamic Therapy Market Value Share Analysis, by Product Type 11.4. North America Photodynamic Therapy Market Forecast, by Product Type 11.4.1. Photosenitizer drugs 11.4.1.1. Hematoporphyrin Derivative (Hpd) 11.4.1.2. Aminolevulinic Acid (ALA) 11.4.1.3. Benzoporphyrin Derivatives 11.4.1.4. Texaphyrins 11.4.1.5. Chlorins 11.4.1.6. Dyes 11.5. North America Photodynamic Therapy Market Value Share Analysis, by Devices 11.6. North America Photodynamic Therapy Market Forecast, by Devices 11.6.1. Disposable fiber optic light delivery devices 11.6.2. Diode lasers 11.7. North America Photodynamic Therapy Market Value Share Analysis, by Application 11.8. North America Photodynamic Therapy Market Forecast, by Application 11.8.1. Basal Cell Carcinoma 11.8.2. Actinic Keratosis 11.8.3. Others 11.9. North America Photodynamic Therapy Market Value Share Analysis, by Country 11.10. North America Photodynamic Therapy Market Forecast, by Country 11.10.1. U.S. 11.10.2. Canada 11.11. North America Photodynamic Therapy Market Analysis, by Country 11.12. U.S. Photodynamic Therapy Market Forecast, by Product Type 11.12.1. Photosenitizer drugs 11.12.1.1. Hematoporphyrin Derivative (Hpd) 11.12.1.2. Aminolevulinic Acid (ALA) 11.12.1.3. Benzoporphyrin Derivatives 11.12.1.4. Texaphyrins 11.12.1.5. Chlorins 11.12.1.6. Dyes 11.13. U.S. Photodynamic Therapy Market Forecast, by Devices 11.13.1. Disposable fiber optic light delivery devices 11.13.2. Diode lasers 11.14. U.S. Photodynamic Therapy Market Forecast, by Application 11.14.1. Basal Cell Carcinoma 11.14.2. Actinic Keratosis 11.14.3. Others 11.15. Canada Photodynamic Therapy Market Forecast, by Product Type 11.15.1. Photosenitizer drugs 11.15.1.1. Hematoporphyrin Derivative (Hpd) 11.15.1.2. Aminolevulinic Acid (ALA) 11.15.1.3. Benzoporphyrin Derivatives 11.15.1.4. Texaphyrins 11.15.1.5. Chlorins 11.15.1.6. Dyes 11.16. Steel Canada Photodynamic Therapy Market Forecast, by Devices 11.16.1. Disposable fiber optic light delivery devices 11.16.2. Diode lasers 11.17. Canada Photodynamic Therapy Market Forecast, by Application 11.17.1. Basal Cell Carcinoma 11.17.2. Actinic Keratosis 11.17.3. Others 11.18. North America Photodynamic Therapy Market Attractiveness Analysis 11.18.1. By Product Type 11.18.2. By Devices 11.18.3. By Application 11.19. PEST Analysis 11.20. Key Trends 11.21. Key Developments 12. Europe Photodynamic Therapy Market Analysis 12.1. Key Findings 12.2. Europe Photodynamic Therapy Market Overview 12.3. Europe Photodynamic Therapy Market Value Share Analysis, by Product Type 12.4. Europe Photodynamic Therapy Market Forecast, by Product Type 12.4.1. Photosenitizer drugs 12.4.1.1. Hematoporphyrin Derivative (Hpd) 12.4.1.2. Aminolevulinic Acid (ALA) 12.4.1.3. Benzoporphyrin Derivatives 12.4.1.4. Texaphyrins 12.4.1.5. Chlorins 12.4.1.6. Dyes 12.5. Europe Photodynamic Therapy Market Value Share Analysis, by Devices 12.6. Europe Photodynamic Therapy Market Forecast, by Devices 12.6.1. Disposable fiber optic light delivery devices 12.6.2. Diode lasers 12.7. Europe Photodynamic Therapy Market Value Share Analysis, by Application 12.8. Europe Photodynamic Therapy Market Forecast, by Application 12.8.1. Basal Cell Carcinoma 12.8.2. Actinic Keratosis 12.8.3. Others 12.9. Europe Photodynamic Therapy Market Value Share Analysis, by Country 12.10. Europe Photodynamic Therapy Market Forecast, by Country 12.10.1. Germany 12.10.2. U.K. 12.10.3. France 12.10.4. Italy 12.10.5. Spain 12.10.6. Rest of Europe 12.11. Europe Photodynamic Therapy Market Analysis, by Country 12.12. Germany Photodynamic Therapy Market Forecast, by Product Type 12.12.1. Photosenitizer drugs 12.12.1.1. Hematoporphyrin Derivative (Hpd) 12.12.1.2. Aminolevulinic Acid (ALA) 12.12.1.3. Benzoporphyrin Derivatives 12.12.1.4. Texaphyrins 12.12.1.5. Chlorins 12.12.1.6. Dyes 12.13. Germany Photodynamic Therapy Market Forecast, by Devices 12.13.1. Disposable fiber optic light delivery devices 12.13.2. Diode lasers 12.14. Germany Photodynamic Therapy Market Forecast, by Application 12.14.1. Basal Cell Carcinoma 12.14.2. Actinic Keratosis 12.14.3. Others 12.15. U.K. Photodynamic Therapy Market Forecast, by Product Type 12.15.1. Photosenitizer drugs 12.15.1.1. Hematoporphyrin Derivative (Hpd) 12.15.1.2. Aminolevulinic Acid (ALA) 12.15.1.3. Benzoporphyrin Derivatives 12.15.1.4. Texaphyrins 12.15.1.5. Chlorins 12.15.1.6. Dyes 12.16. U.K. Photodynamic Therapy Market Forecast, by Devices 12.16.1. Disposable fiber optic light delivery devices 12.16.2. Diode lasers 12.17. U.K. Photodynamic Therapy Market Forecast, by Application 12.17.1. Basal Cell Carcinoma 12.17.2. Actinic Keratosis 12.17.3. Others 12.18. France Photodynamic Therapy Market Forecast, by Product Type 12.18.1. Photosenitizer drugs 12.18.1.1. Hematoporphyrin Derivative (Hpd) 12.18.1.2. Aminolevulinic Acid (ALA) 12.18.1.3. Benzoporphyrin Derivatives 12.18.1.4. Texaphyrins 12.18.1.5. Chlorins 12.18.1.6. Dyes 12.19. France Photodynamic Therapy Market Forecast, by Devices 12.19.1. Disposable fiber optic light delivery devices 12.19.2. Diode lasers 12.20. France Photodynamic Therapy Market Forecast, by Application 12.20.1. Basal Cell Carcinoma 12.20.2. Actinic Keratosis 12.20.3. Others 12.21. Italy Photodynamic Therapy Market Forecast, by Product Type 12.21.1. Photosenitizer drugs 12.21.1.1. Hematoporphyrin Derivative (Hpd) 12.21.1.2. Aminolevulinic Acid (ALA) 12.21.1.3. Benzoporphyrin Derivatives 12.21.1.4. Texaphyrins 12.21.1.5. Chlorins 12.21.1.6. Dyes 12.22. Italy Photodynamic Therapy Market Forecast, by Devices 12.22.1. Disposable fiber optic light delivery devices 12.22.2. Diode lasers 12.23. Italy Photodynamic Therapy Market Forecast, by Application 12.23.1. Basal Cell Carcinoma 12.23.2. Actinic Keratosis 12.23.3. Others 12.24. Spain Photodynamic Therapy Market Forecast, by Product Type 12.24.1. Photosenitizer drugs 12.24.1.1. Hematoporphyrin Derivative (Hpd) 12.24.1.2. Aminolevulinic Acid (ALA) 12.24.1.3. Benzoporphyrin Derivatives 12.24.1.4. Texaphyrins 12.24.1.5. Chlorins 12.24.1.6. Dyes 12.25. Spain Photodynamic Therapy Market Forecast, by Devices 12.25.1. Disposable fiber optic light delivery devices 12.25.2. Diode lasers 12.26. Spain Photodynamic Therapy Market Forecast, by Application 12.26.1. Basal Cell Carcinoma 12.26.2. Actinic Keratosis 12.26.3. Others 12.27. Rest of Europe Photodynamic Therapy Market Forecast, by Product Type 12.27.1. Photosenitizer drugs 12.27.1.1. Hematoporphyrin Derivative (Hpd) 12.27.1.2. Aminolevulinic Acid (ALA) 12.27.1.3. Benzoporphyrin Derivatives 12.27.1.4. Texaphyrins 12.27.1.5. Chlorins 12.27.1.6. Dyes 12.28. Rest of Europe Photodynamic Therapy Market Forecast, by Devices 12.28.1. Disposable fiber optic light delivery devices 12.28.2. Diode lasers 12.29. Rest Of Europe Photodynamic Therapy Market Forecast, by Application 12.29.1. Basal Cell Carcinoma 12.29.2. Actinic Keratosis 12.29.3. Others 12.30. Europe Photodynamic Therapy Market Attractiveness Analysis 12.30.1. By Product Type 12.30.2. By Devices 12.30.3. By Application 12.31. PEST Analysis 12.32. Key Trends 12.33. Key Developments 13. Asia Pacific Photodynamic Therapy Market Analysis 13.1. Key Findings 13.2. Asia Pacific Photodynamic Therapy Market Overview 13.3. Asia Pacific Photodynamic Therapy Market Value Share Analysis, by Product Type 13.4. Asia Pacific Photodynamic Therapy Market Forecast, by Product Type 13.4.1. Photosenitizer drugs 13.4.1.1. Hematoporphyrin Derivative (Hpd) 13.4.1.2. Aminolevulinic Acid (ALA) 13.4.1.3. Benzoporphyrin Derivatives 13.4.1.4. Texaphyrins 13.4.1.5. Chlorins 13.4.1.6. Dyes 13.5. Asia Pacific Photodynamic Therapy Market Value Share Analysis, by Devices 13.6. Asia Pacific Photodynamic Therapy Market Forecast, by Devices 13.6.1. Disposable fiber optic light delivery devices 13.6.2. Diode lasers 13.7. Asia Pacific Photodynamic Therapy Market Value Share Analysis, by Application 13.8. Asia Pacific Photodynamic Therapy Market Forecast, by Application 13.8.1. Basal Cell Carcinoma 13.8.2. Actinic Keratosis 13.8.3. Others 13.9. Asia Pacific Photodynamic Therapy Market Value Share Analysis, by Country 13.10. Asia Pacific Photodynamic Therapy Market Forecast, by Country 13.10.1. China 13.10.2. India 13.10.3. Japan 13.10.4. ASEAN 13.10.5. Rest of Asia Pacific 13.11. Asia Pacific Photodynamic Therapy Market Analysis, by Country 13.12. China Photodynamic Therapy Market Forecast, by Product Type 13.12.1. Photosenitizer drugs 13.12.1.1. Hematoporphyrin Derivative (Hpd) 13.12.1.2. Aminolevulinic Acid (ALA) 13.12.1.3. Benzoporphyrin Derivatives 13.12.1.4. Texaphyrins 13.12.1.5. Chlorins 13.12.1.6. Dyes 13.13. China Photodynamic Therapy Market Forecast, by Devices 13.13.1. Disposable fiber optic light delivery devices 13.13.2. Diode lasers 13.14. China Photodynamic Therapy Market Forecast, by Application 13.14.1. Basal Cell Carcinoma 13.14.2. Actinic Keratosis 13.14.3. Others 13.15. India Photodynamic Therapy Market Forecast, by Product Type 13.15.1. Photosenitizer drugs 13.15.1.1. Hematoporphyrin Derivative (Hpd) 13.15.1.2. Aminolevulinic Acid (ALA) 13.15.1.3. Benzoporphyrin Derivatives 13.15.1.4. Texaphyrins 13.15.1.5. Chlorins 13.15.1.6. Dyes 13.16. India Photodynamic Therapy Market Forecast, by Devices 13.16.1. Disposable fiber optic light delivery devices 13.16.2. Diode lasers 13.17. India Photodynamic Therapy Market Forecast, by Application 13.17.1. Basal Cell Carcinoma 13.17.2. Actinic Keratosis 13.17.3. Others 13.18. Japan Photodynamic Therapy Market Forecast, by Product Type 13.18.1. Photosenitizer drugs 13.18.1.1. Hematoporphyrin Derivative (Hpd) 13.18.1.2. Aminolevulinic Acid (ALA) 13.18.1.3. Benzoporphyrin Derivatives 13.18.1.4. Texaphyrins 13.18.1.5. Chlorins 13.18.1.6. Dyes 13.19. Japan Photodynamic Therapy Market Forecast, by Devices 13.19.1. Disposable fiber optic light delivery devices 13.19.2. Diode lasers 13.20. Japan Photodynamic Therapy Market Forecast, by Application 13.20.1. Basal Cell Carcinoma 13.20.2. Actinic Keratosis 13.20.3. Others 13.21. ASEAN Photodynamic Therapy Market Forecast, by Product Type 13.21.1. Photosenitizer drugs 13.21.1.1. Hematoporphyrin Derivative (Hpd) 13.21.1.2. Aminolevulinic Acid (ALA) 13.21.1.3. Benzoporphyrin Derivatives 13.21.1.4. Texaphyrins 13.21.1.5. Chlorins 13.21.1.6. Dyes 13.22. ASEAN Photodynamic Therapy Market Forecast, by Devices 13.22.1. Disposable fiber optic light delivery devices 13.22.2. Diode lasers 13.23. ASEAN Photodynamic Therapy Market Forecast, by Application 13.23.1. Basal Cell Carcinoma 13.23.2. Actinic Keratosis 13.23.3. Others 13.24. Rest of Asia Pacific Photodynamic Therapy Market Forecast, by Product Type 13.24.1. Photosenitizer drugs 13.24.1.1. Hematoporphyrin Derivative (Hpd) 13.24.1.2. Aminolevulinic Acid (ALA) 13.24.1.3. Benzoporphyrin Derivatives 13.24.1.4. Texaphyrins 13.24.1.5. Chlorins 13.24.1.6. Dyes 13.25. Rest of Asia Pacific Photodynamic Therapy Market Forecast, by Devices 13.25.1. Disposable fiber optic light delivery devices 13.25.2. Diode lasers 13.26. Rest of Asia Pacific Photodynamic Therapy Market Forecast, by Application 13.26.1. Basal Cell Carcinoma 13.26.2. Actinic Keratosis 13.26.3. Others 13.27. Asia Pacific Photodynamic Therapy Market Attractiveness Analysis 13.27.1. By Product Type 13.27.2. By Devices 13.27.3. By Application 13.28. PEST Analysis 13.29. Key Trends 13.30. Key Developments 14. Middle East & Africa Photodynamic Therapy Market Analysis 14.1. Key Findings 14.2. Middle East & Africa Photodynamic Therapy Market Overview 14.3. Middle East & Africa Photodynamic Therapy Market Value Share Analysis, by Product Type 14.4. Middle East & Africa Photodynamic Therapy Market Forecast, by Product Type 14.4.1. Photosenitizer drugs 14.4.1.1. Hematoporphyrin Derivative (Hpd) 14.4.1.2. Aminolevulinic Acid (ALA) 14.4.1.3. Benzoporphyrin Derivatives 14.4.1.4. Texaphyrins 14.4.1.5. Chlorins 14.4.1.6. Dyes 14.5. Middle East & Africa Photodynamic Therapy Market Value Share Analysis, by Devices 14.6. Middle East & Africa Photodynamic Therapy Market Forecast, by Devices 14.6.1. Disposable fiber optic light delivery devices 14.6.2. Diode lasers 14.7. Middle East & Africa Photodynamic Therapy Market Value Share Analysis, by Application 14.8. Middle East & Africa Photodynamic Therapy Market Forecast, by Application 14.8.1. Basal Cell Carcinoma 14.8.2. Actinic Keratosis 14.8.3. Others 14.9. Middle East & Africa Photodynamic Therapy Market Value Share Analysis, by Country 14.10. Middle East & Africa Photodynamic Therapy Market Forecast, by Country 14.10.1. GCC 14.10.2. South Africa 14.10.3. Rest of Middle East & Africa 14.11. Middle East & Africa Photodynamic Therapy Market Analysis, by Country 14.12. GCC Photodynamic Therapy Market Forecast, by Product Type 14.12.1. Photosenitizer drugs 14.12.1.1. Hematoporphyrin Derivative (Hpd) 14.12.1.2. Aminolevulinic Acid (ALA) 14.12.1.3. Benzoporphyrin Derivatives 14.12.1.4. Texaphyrins 14.12.1.5. Chlorins 14.12.1.6. Dyes 14.13. GCC Photodynamic Therapy Market Forecast, by Devices 14.13.1. Disposable fiber optic light delivery devices 14.13.2. Diode lasers 14.14. GCC Photodynamic Therapy Market Forecast, by Application 14.14.1. Basal Cell Carcinoma 14.14.2. Actinic Keratosis 14.14.3. Others 14.15. South Africa Photodynamic Therapy Market Forecast, by Product Type 14.15.1. Photosenitizer drugs 14.15.1.1. Hematoporphyrin Derivative (Hpd) 14.15.1.2. Aminolevulinic Acid (ALA) 14.15.1.3. Benzoporphyrin Derivatives 14.15.1.4. Texaphyrins 14.15.1.5. Chlorins 14.15.1.6. Dyes 14.16. South Africa Photodynamic Therapy Market Forecast, by Devices 14.16.1. Disposable fiber optic light delivery devices 14.16.2. Diode lasers 14.17. South Africa Photodynamic Therapy Market Forecast, by Application 14.17.1. Basal Cell Carcinoma 14.17.2. Actinic Keratosis 14.17.3. Others 14.18. Rest of Middle East & Africa Photodynamic Therapy Market Forecast, by Product Type 14.18.1. Photosenitizer drugs 14.18.1.1. Hematoporphyrin Derivative (Hpd) 14.18.1.2. Aminolevulinic Acid (ALA) 14.18.1.3. Benzoporphyrin Derivatives 14.18.1.4. Texaphyrins 14.18.1.5. Chlorins 14.18.1.6. Dyes 14.19. Rest of Middle East & Africa Photodynamic Therapy Market Forecast, by Devices 14.19.1. Disposable fiber optic light delivery devices 14.19.2. Diode lasers 14.20. Rest of Middle East & Africa Photodynamic Therapy Market Forecast, by Application 14.20.1. Basal Cell Carcinoma 14.20.2. Actinic Keratosis 14.20.3. Others 14.21. Middle East & Africa Photodynamic Therapy Market Attractiveness Analysis 14.21.1. By Product Type 14.21.2. By Devices 14.21.3. By Application 14.22. PEST Analysis 14.23. Key Trends 14.24. Key Developments 15. South America Photodynamic Therapy Market Analysis 15.1. Key Findings 15.2. South America Photodynamic Therapy Market Overview 15.3. South America Photodynamic Therapy Market Value Share Analysis, by Product Type 15.4. South America Photodynamic Therapy Market Forecast, by Product Type 15.4.1. Photosenitizer drugs 15.4.1.1. Hematoporphyrin Derivative (Hpd) 15.4.1.2. Aminolevulinic Acid (ALA) 15.4.1.3. Benzoporphyrin Derivatives 15.4.1.4. Texaphyrins 15.4.1.5. Chlorins 15.4.1.6. Dyes 15.5. South America Photodynamic Therapy Market Value Share Analysis, by Devices 15.6. South America Photodynamic Therapy Market Forecast, by Devices 15.6.1. Disposable fiber optic light delivery devices 15.6.2. Diode lasers 15.7. South America Photodynamic Therapy Market Value Share Analysis, by Application 15.8. South America Photodynamic Therapy Market Forecast, by Application 15.8.1. Basal Cell Carcinoma 15.8.2. Actinic Keratosis 15.8.3. Others 15.9. South America Photodynamic Therapy Market Value Share Analysis, by Country 15.10. South America Photodynamic Therapy Market Forecast, by Country 15.10.1. Brazil 15.10.2. Mexico 15.10.3. Rest of South America 15.11. South America Photodynamic Therapy Market Analysis, by Country 15.12. Brazil Photodynamic Therapy Market Forecast, by Product Type 15.12.1. Photosenitizer drugs 15.12.1.1. Hematoporphyrin Derivative (Hpd) 15.12.1.2. Aminolevulinic Acid (ALA) 15.12.1.3. Benzoporphyrin Derivatives 15.12.1.4. Texaphyrins 15.12.1.5. Chlorins 15.12.1.6. Dyes 15.13. Brazil Photodynamic Therapy Market Forecast, by Devices 15.13.1. Disposable fiber optic light delivery devices 15.13.2. Diode lasers 15.14. Brazil Photodynamic Therapy Market Forecast, by Application 15.14.1. Basal Cell Carcinoma 15.14.2. Actinic Keratosis 15.14.3. Others 15.15. Mexico Photodynamic Therapy Market Forecast, by Product Type 15.15.1. Photosenitizer drugs 15.15.1.1. Hematoporphyrin Derivative (Hpd) 15.15.1.2. Aminolevulinic Acid (ALA) 15.15.1.3. Benzoporphyrin Derivatives 15.15.1.4. Texaphyrins 15.15.1.5. Chlorins 15.15.1.6. Dyes 15.16. Mexico Photodynamic Therapy Market Forecast, by Devices 15.16.1. Disposable fiber optic light delivery devices 15.16.2. Diode lasers 15.17. Mexico Photodynamic Therapy Market Forecast, by Application 15.17.1. Basal Cell Carcinoma 15.17.2. Actinic Keratosis 15.17.3. Others 15.18. Rest of South America Photodynamic Therapy Market Forecast, by Product Type 15.18.1. Photosenitizer drugs 15.18.1.1. Hematoporphyrin Derivative (Hpd) 15.18.1.2. Aminolevulinic Acid (ALA) 15.18.1.3. Benzoporphyrin Derivatives 15.18.1.4. Texaphyrins 15.18.1.5. Chlorins 15.18.1.6. Dyes 15.19. Rest of South America Photodynamic Therapy Market Forecast, by Devices 15.19.1. Disposable fiber optic light delivery devices 15.19.2. Diode lasers 15.20. Rest of South America Photodynamic Therapy Market Forecast, by Application 15.20.1. Basal Cell Carcinoma 15.20.2. Actinic Keratosis 15.20.3. Other 15.21. South America Photodynamic Therapy Market Attractiveness Analysis 15.21.1. By Product Type 15.21.2. By Devices 15.21.3. By Application 15.22. PEST Analysis 15.23. Key Trends 15.24. Key Developments 16. Company Profiles 16.1. Market Share Analysis, by Company 16.2. Competition Matrix 16.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 16.2.2. New Product Launches and Product Enhancements 16.2.3. Market Consolidation 16.2.3.1. M&A by Regions, Investment and Applications 16.2.3.2. M&A Key Players, Forward Integration and Backward Integration 16.3. Company Profiles: Key Players 16.3.1. Sun Pharmaceutical Industries Ltd. 16.3.1.1. Company Overview 16.3.1.2. Financial Overview 16.3.1.3. Product Portfolio 16.3.1.4. Business Strategy 16.3.1.5. Recent Developments 16.3.1.6. Company Footprint 16.3.2. Hologic, Inc. 16.3.3. Allergan Plc. 16.3.4. Galderma SA 16.3.5. Quest PharmaTech Inc. 16.3.6. Biofrontera AG 16.3.7. anofi 16.3.8. DUSA Pharmaceuticals 16.3.9. Bausch Health 16.3.10. Beiersdorf 16.3.11. Soligenix 16.3.12. Theralase Technologies 16.3.13. Quest Pharmatech 16.3.14. Galderma 16.3.15. Biofrontera 16.3.16. Lumenis 16.3.17. PhotoMedex 16.3.18. Biolitec 16.3.19. Ambicare Health 17. Primary Key Insights

About This Report

Report ID45186
Category Automation & Process Control
Published DateJan 2020
No of Pages183
Contact Us